期刊文献+

伊贝沙坦治疗高血压病的疗效及对血管内皮功能的影响 被引量:3

Estimation of therapeutic effectiveness of irbesartan on hypertension and vascular endothelial function
原文传递
导出
摘要 目的 观察伊贝沙坦对高血压病 (EH)病人的疗效及内皮血管活性物质内皮素 1(ET 1)、一氧化氮 (NO)、降钙素基因相关肽 (CGRP)和血管紧张素Ⅱ(AngⅡ)的影响。方法  6 0例EH病人用伊贝沙坦治疗 8周 ,观察用药前后血ET、NO、CGRP和AngⅡ的变化。 结果 伊贝沙坦治疗EH总有效率为 91 7%。伊贝沙坦治疗后血NO、CGRP浓度均较治疗前显著升高 (P <0 0 1) ,血ET浓度显著下降 (P <0 0 1) ,AngⅡ水平也升高 (P <0 0 1)。结论 伊贝沙坦有较好的降压作用 ,可明显改善EH病人血管内皮功能。 Objective To evaluate the effects of irbesartan on essential hypertension(EH) and endothelial vaso-active substances,such as endothelin-1(ET-1),nitric oxide(NO),calcitonin gene-related peptide(CGRF) and angiotensin Ⅱ(AngⅡ) in blood.Methods 60 cases of EH patients were treated with irbesartan for 8 weeks,the changes in ET,NO,CGRF and AngⅡ in blood were observed.Results A total of 91.7% of EH cases were treated effectively.The concentrations of NO,CGRF and AngⅡ in blood significantly increased after tretament(P<0.01),but the concentration of ET in blood significantly decreased(P<0.01).Conclusion Irbesartan has good action in decreasing blood pressure,it can significantly improve vascular endothelial function of EH patients.
出处 《中国基层医药》 CAS 2004年第5期527-528,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 伊贝沙坦 药物治疗 高血压病 血管内皮功能 内皮素1 一氧化氮 降钙素基因相关肽 Irbesartan Hypertension Endothelin-1(ET-1) NNitric oxide(NO) Calcitonin gene-related peptide(CGRF) Angiotensin Ⅱ(AngⅡ)
  • 相关文献

参考文献2

二级参考文献43

  • 1[1]Bjorn Dahlof.Left ventricular hypertrophy and angiotensin Ⅱ antagonist[J].AJH,2001,14:174-182.
  • 2[2]Ospedale G.Casati,Carnovali [M].Clin Ter,2001 Mar-Apr,152(2):103-6.
  • 3[3]Mascareno E,Siddiqui MA.The role of Jak/STAT signaling in heart tissue renin-angiotensin system[J].Mol Cell Biochem,2000 Sep,212(1-2):171-5.
  • 4[4]Schmieder RE,Erdmann J,Delles C et al.Effect of the angiotensin Ⅱ type 2-receptor gene (+1675 G/A) on left ventricular structure in humans[J].J Am Coll Cardiol,2001 Jan,37(1):175-82.
  • 5[5]Tamura K,Chen YE,Chen Q et al.Expression of renin-angiotensin system and extracellular matrix genes in cardiovascular cells and its regulation through AT1 receptor[J].Mol Cell Biochem,2000 Sep,212(1-2):203-9.
  • 6[6]Matsubara H.Pathophysiological role of angiotensin Ⅱ type 2 receptor in cardiovascular and renal diseases[J].Circ Res,1998,83:1182-1191.
  • 7[7]Bartunek J,Weinberg EO,Tajima M,et al.Angiotensin Ⅱ type 2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin Ⅱ in hypertrophied heart[J].Circulation,1999,99:22-25.
  • 8[8]Kuizinga MC,Smits JFM,Arends JW,et al.AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction[J].J Mol Cell Cardiol,1998,30:425-434.
  • 9[9]Tamura M,Wanaka Y,Landon EJ,et al.Intracellular sodium modulates the expression of angiotensin Ⅱ subtype 2 receptor in PC12W cells[J].Hypertension,1999,33:626-632.
  • 10[10]Sandmann S,Yu M,Kaschina E et al.Differential effects of angiotensin AT1 and AT2 receptors on the expression:translation and function of the Na+-H+ exchanger and Na+-HCO3-synporter in the rat heart after myocardial infarction[J].J Am Coll Cardiol,2001 Jun 15,37(8):2154-65.

共引文献12

同被引文献33

  • 1黄晓真,黄梅,张梅,张运.卡维地洛对原发性高血压患者血管内皮功能的干预作用[J].中国基层医药,2004,11(12):1420-1421. 被引量:2
  • 2牛国平.高血压病患者血清IGF-Ⅱ和VEGF检测的临床意义[J].放射免疫学杂志,2006,19(2):97-98. 被引量:5
  • 3冯润川,潘华,许丁空,陈富荣.替米沙坦和福辛普利对高血压左室肥厚患者血浆内皮素和一氧化氮浓度的影响[J].江苏医药,2007,33(4):350-352. 被引量:6
  • 4Pearson TA,Mensah GA,Alexander RW.Markers of inflammation and cardiovascular disease:application to clinical and public health practice:A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American HeartAssociatio.Circulation,2003,107(3):499-511.
  • 5Wallace SM,Yasmin L,McEniery CM,et al.Isolate systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction.Hypertension,2007,50(1):228-233.
  • 6zoghi M,Nalbantgil I.Hypertension and endotheialdysfunction.J Anadolu Kardiyol Derg,2002.2(2):142-147.
  • 7Pagnin E,Giacon V,Zaghetto F,et al.Arterial hypertension and oxidative stress induced by cyclosporine effect of Carvedilol.AnnltalMed int,2001,16(2):101-105.
  • 8Pearson TA, Mensah GA, Alexander RW. Markers of inflammation and cardiovascular disease: application to clinical and public health practice:A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American HeartAssociatio. Circulation ,2003,107 ( 3 ) :499-511.
  • 9Zhang H, Cook D. Cerebral smooth muscle potassium channel and their possible role in the management of vasospasm. Pharmacol Toxicol,2004,75 ( 6 ) : 327-336.
  • 10Spencer CG, Martin SC, Felmmlen DC, et al. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglog Scandinavian Cardiae Outeomes Trail.Int J Cardiol,2007,94(223) :293-300.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部